Resmed stockRMD
Resmed trades at $239.31, 13.4% below its 52-week high (Feb 10, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. −0.1% year to date, −1.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Jan 28, 2027.
Ratings, candles, signals and the screener for RMD — after you log in
Open the terminalFrequently asked questions about Resmed
What is the Resmed stock price?
At the close on Nov 5, 2026: $239.31 (−0.50% on the day). 52-week high: $276.21 on Feb 10, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Resmed report earnings?
The next quarterly report is on Jan 28, 2027. Last quarter, earnings per share changed +14% year over year, revenue +6%.
Does Resmed pay dividends?
Yes, the dividend yield is about 1.15% a year.
Where does Resmed trade and how to buy it?
Ticker RMD, exchange NYSE. You can buy it through a broker with access to US exchanges.
Should I buy Resmed now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RMD are in the terminal after you log in.